Consensus Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Real-time Estimate Tradegate Other stock markets 02:15:52 2024-04-19 am EDT			5-day change	1st Jan Change
28.25 ^EUR	+4.09%		-0.15%	+11.28%

Apr. 10	Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark	MT
Apr. 08	AstraZeneca's Enhertu Receives FDA Approval for HER2-Positive Solid Tumor Indication	MT

Evolution of the average Target Price on Daiichi Sankyo Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

bd3.Iqm1KWiIYMwqi7fs7DvO-4nSC0R4PqGf7Nj7dJeZ6Lo.b9DhagC4Orxo6f-pgWObj96HXx0NBvfS2YCRWdrasPMS_NBjKv0CqUjC3A~49793d814e63bb2dd0f4cdabd4e9483f

Analyst Recommendations on Daiichi Sankyo Co., Ltd.

Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy	Feb. 21	MT
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains	Feb. 20	MT
Japan's Nikkei slips after Fed chair signals delay in rate cut	Jan. 31	RE
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen	Dec. 04	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold	23-10-23	MT
Rising Interest Rates Lower Asian Stock Markets	23-10-19	MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen	23-09-25	MT
AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates	23-09-11	DJ
The Fed Opens Its Jackson Hole Conference With Interest Rate Path in Focus	23-08-24	DJ
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy	23-07-13	MT
AstraZeneca's Partner Daiichi Sankyo Says Enhertu Meets Objective Response Rate Target in Solid Tumors Phase 2 Trial	23-03-06	MT
Astrazeneca and Daiichi Sankyo's Enhertu Met Prespecified Criteria for Objective Response Rate and Duration of Response	23-03-06	CI
Japan's Nikkei ends at 1-month low amid political, rate-hike worries	23-02-22	RE
Nikkei drops to 1-month low on political tensions, rate-hike worries	23-02-21	RE
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy	22-12-14	MT
Nikkei little changed, pinned down by rates worry	22-11-20	RE
Japan's Nikkei snaps 5-day losing streak amid US rate caution	22-08-25	RE
MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022	22-06-06
FTSE Flat, PMI Data Adds to Case for Another BoE Rate Increase	22-02-21	DJ
AstraZeneca-Daiichi Sankyo's Enhertu Improves Progression-Free Survival, Objective Response Rate in Brain Metastases Patients	21-12-09	MT
AstraZeneca : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patients	21-09-20	MT
Japanese shares jump on Fed's growth view, rate pledge	21-03-17	RE
Daiichi Sankyo Company, Limited Announces New 12-Month Analysis Data from ETNA-AF Non-Interventional Study Show Low Bleeding and ICH Rates in Frail and Ageing AF Patients on LIXIANA	20-08-31	CI
Japanese stocks slip as economy shrinks at record rate on pandemic hit	20-08-17	RE
Astrazeneca and Daiichi Sankyo Company, Limited Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Tumor Response Rate and Overall Survival in HER2-Positive Metastatic Gastric Cancer in Phase II Destiny-Gastric01 Trial	20-05-29	CI